OncoMatch/Clinical Trials/NCT07677774
GPC3-Targeted PET/CT in Hepatocellular Carcinoma
Is NCT07677774 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for hepatocellular carcinoma (hcc).
NARecruitingThe First Affiliated Hospital of Xiamen UniversityNCT07677774Data as of Sep 2026Location: China
Check if I qualifyExtracted eligibility criteria
Cancer type
Hepatocellular Carcinoma
Demographics
Ages ≤ 80
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07677774 currently recruiting?
Yes, this trial is currently recruiting patients.
Is there an age limit?
Yes. Patients must be 80 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages